30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Amplitude Surgical Growth Driven by U.S. Sales of Foot and Ankle Replacements -

Amplitude Surgical reported FY 1Q20 revenue of €20.8 million (USD $23.4 million), +6.7% vs. FY 1Q19.


  • Amplitude Surgical’s growth was driven by strength of subsidiaries in markets outside of France (+15.9% vs. prior year), with sales in the U.S. nearly doubling compared to FY 1Q19
  • International subsidiary growth was partially offset by a downturn in sales from international distributors (-4.3% vs. prior year)
  • The company’s Novastep foot and ankle product line growth was driven by sales in the U.S.
  • ORTHOWORLD projects Amplitude Surgical full calendar year 2019 orthopedic revenue of $121.3 million, +5.1% vs. 2018


ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows (USD $ millions).

  FY 1Q20 FY 1Q19 $ Chg % Chg
Joint Replacement $22.5 $21.1 $1.4 6.8%
   Knees $11.9 $11.3 $0.6 5.2%
   Hips $8.4 $8.2 $0.2 2.8%
   Extremities $2.2 $1.6 $0.6 39.6%
Sports Medicine $0.7 $0.7 $0.0 1.4%
Orthobiologics $0.2 $0.2 $0.0 6.1%
Total $23.4 $21.9 $1.5 6.7%


Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.